Why hospitals oppose J&J’s change to its 340B discounts

The latest stories trending on MedCity News.

Editor's Pick

Top Story J&J's Change to 340B Discounts is "Inconsistent" with Statute, HRSA Says Johnson & Johnson announced last week a major change in the way it offers 340B pricing for two medications. The change is "inconsistent" with the 340B statute, according to HRSA. INVEST Digital Health: Less Than a Month Away At Pegasus Park in Dallas, healthcare's premier investment conference, INVEST Digital Health will take place on September 18. This conference provides a platform to learn about the latest trends, research, and innovations in the field of digital health, ensuring attendees remain at the forefront of the ever-evolving healthcare landscape.   Stay Ahead of the Curve - Grab Your Ticket Now

Featured News

New Data Network Seeks to Provide Much-Needed Info on GLP-1s OMNY Health — a national data ecosystem that facilitates biotech and medical research — launched a data network consisting of EHR data from more than 645,000 GLP-1 users. The data network seeks to give OMNY's life sciences and health system partners a vast source of GLP-1 data that is related to patient demographics and social determinants of health. A Revolution in Military Medical Staffing is Afoot and Private Sector Firms are Playing a Big Part No revolutionary naval vessels, fighter planes, or weapon systems were involved. Rather, this one was about staffing military healthcare facilities. Make no mistake, though: It's also revolutionary. Increasing Health Equity Through Accessibility and Education Through community engagement, the root causes of healthcare disparities can be addressed, and the health and resiliency of individuals can be dramatically improved.

Resources

MedCity Pivot Podcast: How Sentara Health is Applying Regard's AI Platform In this episode, we speak to a healthtech executive and a physician to see where AI tools can best be deployed in health systems. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe